Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Planning and Dissemination Grant - Institute Community Support

McGill University

$10,000.00

5th Canadian Symposium on Hepatitis C Virus: "We're not done yet: Remaining Challenges in HCV"

FY 2015-16

Summary
Hepatitis C virus (HCV) affects over 268,000 Canadians and causes more years of life lost than any other infectious disease in the country. The CIHR and the Public Health Agency of Canada (PHAC) have identified liver disease due to HCV as a major public health problem. In 2015, new interferon (IFN)-free therapies with high cure rates (>90%) and fewer side effects than previous treatments were approved by Health Canada. Currently, government funding supports these therapies for HCV-infected individuals who have moderate to severe fibrosis (F2 and above); but it is anticipated that in future all HCV patients will be able to engage in care. However, diagnosis and treatment uptake are poor in Canada due to financial, geographical, cultural and social barriers. With financial support from CIHR and non-CIHR sources, the National CIHR Research Training Program in Hepatitis C (NCRTP-HepC) has brought together key HCV researchers and stakeholders annually through the organization of 4 Canadian Symposia on Hepatitis C Virus (CSHCV). The exchange of expertise between social scientists, public health experts, basic science researchers and clinicians established at these symposia is unique in the HCV field, and is essential to improve prevention, diagnosis, initiate effective treatment strategies, and manage the cost to the Canadian health care system. The goal of this CIHR Planning and Dissemination Grant request is to seek support for the 5th CSHCV, to be held on February 26, 2016, which will be organized by the National CIHR Hepatitis C Network (NCHCN). The theme of this year's symposium "We're not done yet: remaining challenges in Hepatitis C" will focus on identifying strategies to enhance prevention, diagnosis, and treatment of HCV using the new highly effective therapies, and will also include discussions on the need for and current state of development of an HCV vaccine, which in conjunction with new therapies could aid in the elimination of HCV in Canada.
Program
Planning and Dissemination Grant - Institute Community Support
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
334744
Name
Sagan Selena M
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Planning and Dissemination - III
Projecttitle
5th Canadian Symposium on Hepatitis C Virus: "We're not done yet: Remaining Challenges in HCV"
Programtype2
Miscellaneous Programs
Orgnameinp2
McGill University
Cihramount2
$10,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Barriers To Care; Disease Burden; Epidemiology; Hepatitis C Virus; National Action Plan; Public Health; Social Sciences; Viral Hepatitis; Virology
Abstract
Hepatitis C virus (HCV) affects over 268,000 Canadians and causes more years of life lost than any other infectious disease in the country. The CIHR and the Public Health Agency of Canada (PHAC) have identified liver disease due to HCV as a major public health problem. In 2015, new interferon (IFN)-free therapies with high cure rates (>90%) and fewer side effects than previous treatments were approved by Health Canada. Currently, government funding supports these therapies for HCV-infected individuals who have moderate to severe fibrosis (F2 and above); but it is anticipated that in future all HCV patients will be able to engage in care. However, diagnosis and treatment uptake are poor in Canada due to financial, geographical, cultural and social barriers. With financial support from CIHR and non-CIHR sources, the National CIHR Research Training Program in Hepatitis C (NCRTP-HepC) has brought together key HCV researchers and stakeholders annually through the organization of 4 Canadian Symposia on Hepatitis C Virus (CSHCV). The exchange of expertise between social scientists, public health experts, basic science researchers and clinicians established at these symposia is unique in the HCV field, and is essential to improve prevention, diagnosis, initiate effective treatment strategies, and manage the cost to the Canadian health care system. The goal of this CIHR Planning and Dissemination Grant request is to seek support for the 5th CSHCV, to be held on February 26, 2016, which will be organized by the National CIHR Hepatitis C Network (NCHCN). The theme of this year's symposium "We're not done yet: remaining challenges in Hepatitis C" will focus on identifying strategies to enhance prevention, diagnosis, and treatment of HCV using the new highly effective therapies, and will also include discussions on the need for and current state of development of an HCV vaccine, which in conjunction with new therapies could aid in the elimination of HCV in Canada.
Competitiondate
201508
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sagan, Selena M
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Infection & Immunity~ $10,000~ $0~